Skip to content

Drug interactions

Lapatinib + Olaparib

Severity: Moderate

Lapatinib and Olaparib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Olaparib is a CYP3A4 substrate and lapatinib may moderately increase its exposure. This may increase anemia, nausea and other olaparib toxicities.

What this interaction means in plain words

Lapatinib and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lapatinib belongs to Oncology; Olaparib belongs to Oncology.

Evidence level: Low

Why it happens

CYP3A4 inhibition by lapatinib reduces olaparib clearance.

What to do

Monitor blood counts and tolerability. If coadministration is needed, reduce the olaparib dose as recommended for moderate CYP3A inhibitors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lapatinib and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lapatinib with Olaparib?

MediHelp rates the interaction as moderate. Lapatinib and Olaparib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Olaparib is a CYP3A4 substrate and lapatinib may moderately increase its exposure. This may increase anemia, nausea and other olaparib toxicities.

How serious is the interaction between Lapatinib and Olaparib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and tolerability. If coadministration is needed, reduce the olaparib dose as recommended for moderate CYP3A inhibitors.

What other medicines interact with Lapatinib?

MediHelp also lists interactions of Lapatinib with, for example, Dofetilide, Ibutilide, Pimozide. The full list is on the Lapatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in